{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"36.8","value":"0.86"},{"groupId":"OG001","spread":"38.0","value":"1.90"},{"groupId":"OG002","spread":"28.9","value":"2.81"},{"groupId":"OG003","spread":"20.9","value":"9.79"},{"groupId":"OG004","spread":"24.6","value":"21.31"},{"groupId":"OG005","spread":"24.9","value":"29.75"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"11"},{"groupId":"OG004","value":"7"},{"groupId":"OG005","value":"6"}],"units":"Participants"}],"title":"Cmax Hx-DR5-01 Cycle 1 (Day 1)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"42.9","value":"0.79"},{"groupId":"OG001","spread":"18.3","value":"2.11"},{"groupId":"OG002","spread":"59.9","value":"1.12"},{"groupId":"OG003","spread":"22.7","value":"8.36"},{"groupId":"OG004","spread":"156.3","value":"13.13"},{"groupId":"OG005","spread":"7.7","value":"29.56"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"2"}],"units":"Participants"}],"title":"Cmax Hx-DR5-01 Cycle 2 (Day 1)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"16.6","value":"0.89"},{"groupId":"OG001","spread":"53.9","value":"1.82"},{"groupId":"OG002","spread":"146.4","value":"0.89"},{"groupId":"OG003","spread":"11.2","value":"7.20"},{"groupId":"OG004","spread":"24.7","value":"20.35"},{"comment":"Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.","groupId":"OG005","spread":"NA","value":"28.80"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"1"}],"units":"Participants"}],"title":"Cmax Hx-DR5-01 Cycle 3 (Day 1)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"45.2","value":"0.87"},{"groupId":"OG001","spread":"35.7","value":"1.81"},{"groupId":"OG002","spread":"31.8","value":"2.82"},{"groupId":"OG003","spread":"17.0","value":"9.72"},{"groupId":"OG004","spread":"21.9","value":"20.90"},{"groupId":"OG005","spread":"27.9","value":"29.44"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"11"},{"groupId":"OG004","value":"7"},{"groupId":"OG005","value":"6"}],"units":"Participants"}],"title":"Cmax Hx-DR5-05 Cycle 1 (Day 1)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.9","value":"0.79"},{"groupId":"OG001","spread":"18.3","value":"2.00"},{"groupId":"OG002","spread":"76.2","value":"1.11"},{"groupId":"OG003","spread":"25.8","value":"7.75"},{"groupId":"OG004","spread":"14.3","value":"20.37"},{"groupId":"OG005","spread":"5.8","value":"30.52"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"8"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"2"}],"units":"Participants"}],"title":"Cmax Hx-DR5-05 Cycle 2 (Day 1)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"26.6","value":"0.87"},{"groupId":"OG001","spread":"93.8","value":"1.28"},{"groupId":"OG002","spread":"108.2","value":"1.62"},{"groupId":"OG003","spread":"20.6","value":"6.77"},{"groupId":"OG004","spread":"577.8","value":"5.27"},{"comment":"Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.","groupId":"OG005","spread":"NA","value":"28.50"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"1"}],"units":"Participants"}],"title":"Cmax Hx-DR5-05 Cycle 3 (Day 1)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"11"},{"groupId":"OG004","value":"7"},{"groupId":"OG005","value":"6"}],"units":"Participants"}],"description":"The Cmax of Hx-DR5-01 and Hx-DR5-05 are reported.","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"Participants received 0.1 mg/kg of GEN1029 every 2 weeks (Q2W) until the end of treatment.","id":"OG000","title":"Biweekly Regimen (GEN1029 0.1 mg/kg)"},{"description":"Participants received 0.2 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG001","title":"Biweekly Regimen (GEN1029 0.2 mg/kg)"},{"description":"Participants received 0.3 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG002","title":"Biweekly Regimen (GEN1029 0.3 mg/kg)"},{"description":"Participants received 1.0 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG003","title":"Biweekly Regimen (GEN1029 1.0 mg/kg)"},{"description":"Participants received 2.0 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG004","title":"Biweekly Regimen (GEN1029 2.0 mg/kg)"},{"description":"Participants received 3.0 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG005","title":"Biweekly Regimen (GEN1029 3.0 mg/kg)"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Pharmacokinetic (PK) analysis set included all participants who were exposed to at least 1 dose of GEN1029 and who had at least 1 post-dose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.","reportingStatus":"POSTED","timeFrame":"Predose, end of infusion, 2, 4, 24, 48, 168 and 336 hours after end of infusion on Day 1 of Cycles 1, 2, 3","title":"Maximum Observed Plasma Concentration (Cmax) of Hx-DR5-01 and Hx-DR5-05","type":"SECONDARY","unitOfMeasure":"µg/mL"}